Articles Tagged With: RSV
-
Form Follows Function — Structure-Based Vaccines Make Progress Against RSV
In older patients who are at risk for severe disease caused by respiratory syncytial virus (RSV), two new distinct vaccine candidates based on the stabilized prefusion F protein demonstrated efficacy and prevented RSV lower respiratory tract disease in patients older than age 60 years.
-
FDA Streamlining COVID-19 Shot to a Single Formula
Conceding the various vaccine doses and multiple boosters have caused considerable confusion, and some degree of pandemic apathy, the FDA’s Vaccines and Related Biological Products Advisory Committee unanimously voted to simplify and “harmonize” the process by switching to a single vaccine formula to be administered annually for most people.
-
RSV Bronchiolitis Has Persisting Consequences for Some Children
Young children hospitalized with respiratory syncytial virus (RSV) infection are at increased risk of subsequent hospitalization during the following year and of increased need for outpatient healthcare.
-
Leapfrog Group Finds ‘Significant’ Safety Improvement Over 10 Years
Hospitals in the United States have improved patient safety measures significantly over the past decade, according to the latest report from the Leapfrog Group.
-
Healthcare Workers Weather Respiratory Onslaught
In a seemingly interminable viral winter, healthcare workers are facing a rare convergence of a pandemic virus and unusually high levels of seasonal flu and respiratory syncytial virus. Some are tired and sick; others sick of being tired. As EDs stretch capacity to the limits to treat respiratory patients, others with various conditions and critical needs are backed up.
-
2022-2023: A Severe Season for Respiratory Syncytial Virus
The 2022-2023 northern hemisphere respiratory syncytial virus (RSV) season began with fury, crowding hospitals and making many young children extremely ill. Meanwhile, advancing research points to potential means of better preventing RSV infection.
-
Viral Swarm: ‘Tripledemic’ Pushes Healthcare Facilities to the Brink
Respiratory infections are causing hospitalizations and deaths nationally in an unprecedented trifecta of influenza, respiratory syncytial virus, and COVID-19.
-
2022-2023: A Severe Season for Respiratory Syncytial Virus
The 2022-2023 northern hemisphere respiratory syncytial virus (RSV) season began with fury, crowding hospitals and making many young children extremely ill. Meanwhile, advancing research points to potential means of better preventing RSV infection.
-
Optimism for New Interventions to Prevent Respiratory Syncytial Virus Infections
Previous vaccines for respiratory syncytial virus infection in children caused more harm than good. However, new vaccines and preventive monoclonal antibody treatments are nearing final stages of prelicensure testing.
-
Bronchiolitis
MONOGRAPH: A thorough review of guidelines to assist in the care of patients with this debilitating condition.